ArticleLasers in medical science2026
The efficacy of 1064-nm Nd: YAG picosecond laser for Becker's nevus: a retrospective analysis of 49 cases.
Article in Lasers in medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Becker's nevus (BN) is a benign, unilateral hamartoma characterized by hyperpigmentation and hypertrichosis. Laser and light-based therapies represent the primary treatment modalities. To evaluate the efficacy and safety of the 1064-nm Nd: YAG picosecond laser in the treatment of Becker's nevus in a Chinese population. This was a retrospective, single-center study of patients with BN treated between March 2021 and August 2025. Efficacy was assessed via photographic evaluation by two independent dermatologists using a 4-point improvement scale. All patients were treated with 1064-nm Nd: YAG picosecond laser (Picoway, Zoom handpiece, Candela, Wayland, MA USA). SPSS 19 (IBM, Armonk, NY, USA) was used for all statistical analyses. 49patients (18 females, 31 males) with BN were included,24 patients presented with hypertrichosis, 25 patients without hypertrichosis. 25 patients without hypertrichosis were only treated with the 1064-nm Nd: YAG picosecond laser, and the number of treatment sessions was positively correlated with the treatment efficacy (r = 0.615, r²=0.378, P < 0.01). There was no correlation between pigmentation improvement and the number of treatment sessions in the 24 patients with Becker's nevus accompanied by hypertrichosis (r = 0.209, r²=0.044, P>0.05).Adverse events were transient and included pain, erythema, edema, hypopigmentation, and hyperpigmentation. Single-center, retrospective design, lack of a control group. The 1064-nm Nd: YAG picosecond laser is a well-tolerated treatment option for Becker's nevus, demonstrating moderate efficacy. A significant moderate positive correlation was observed between the number of treatments and clinical outcome in Becker's nevus without hypertrichosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.